Over the past 30 months, Bridge has evolved to focus on providing interim Chief Commercial Officer (iCCO) leadership to late Phase IIb and Phase III companies. What was “Bridge Consulting” is now “Bridge – your iCCO company.”
Bridge, provides “hands on” vital interim Chief Commercial Officer (iCCO) leadership to identify, prioritize and execute the commercial imperatives required to successfully launch a Phase III drug and provide ongoing and consistent leadership to the Executive Team and Board until the CCO is hired. The Bridge commercialization model absorbs the company’s risk of hiring a CCO prior to pivotal trial data readout.
In that transition, we have “rebranded” and vastly revamped our website.
In the months ahead, I’ll be providing more color and insight regarding early commercialization and our iCCO leadership.
Please have a look at the new site – I’d be thrilled to hear from you in the new year!